Terms: = Cervical cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
159 results:
1. Prevalence of PD-L1 in cervical cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
Bräutigam K; Schmidt T; Baur M; Tauber N; Kontomanolis EN; Hemptenmacher F; Rody A; Köster F
Anticancer Res; 2024 Feb; 44(2):503-510. PubMed ID: 38307554
[TBL] [Abstract] [Full Text] [Related]
2. Four undescribed coumarin derivatives, with ten amides from the roots of Ficus hirta and their cytotoxic activities.
Ye XS; Tian WJ; Wang GH; Hu LJ; Leng CL; Sun BL; Liu W; Shu XJ; Chen HF
Bioorg Chem; 2024 Mar; 144():107116. PubMed ID: 38237391
[TBL] [Abstract] [Full Text] [Related]
3. Irradiated Cell-derived Exosomes Enhance Cell Proliferation and Radioresistance
Dong Y; Tamari K; Kishigami M; Katsuki S; Minami K; Tatekawa S; Shimizu S; Koizumi M; Ogawa K
Cancer Genomics Proteomics; 2024; 21(1):12-17. PubMed ID: 38151290
[TBL] [Abstract] [Full Text] [Related]
4. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
5. Alkaloids from
Wan Q; Xu J; Zhu C; Liu X; Tu Y; Lei J; Yu J
J Agric Food Chem; 2023 Jul; 71(27):10349-10360. PubMed ID: 37392181
[No Abstract] [Full Text] [Related]
6. Tumor Necrosis Factor-
Chen X; Lin L; Wu Q; Li S; Wang H; Sun Y
Mediators Inflamm; 2023; 2023():5679966. PubMed ID: 37124061
[TBL] [Abstract] [Full Text] [Related]
7. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
8. [Extracellular Signal-regulated Kinase 1/2 Signaling Regulates Cell Invasion:a Review].
Ge XY; Shao LL; Gao XL; He RX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):155-160. PubMed ID: 36861170
[TBL] [Abstract] [Full Text] [Related]
9. CLEFMA induces intrinsic and extrinsic apoptotic pathways through erk1/2 and p38 signalling in uterine cervical cancer cells.
Lee CY; Hsiao YH; Chen PN; Wu HH; Lu CY; Yang SF; Wang PH
J Cell Mol Med; 2023 Feb; 27(3):446-455. PubMed ID: 36645157
[TBL] [Abstract] [Full Text] [Related]
10. Resveratrol against cervical cancer: Evidence from In Vitro and In Vivo Studies.
Nadile M; Retsidou MI; Gioti K; Beloukas A; Tsiani E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558430
[TBL] [Abstract] [Full Text] [Related]
11. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/erk signaling pathway.
Weng K; Li L; Zhou H
Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
[TBL] [Abstract] [Full Text] [Related]
12. HeLa cervical cancer Cells Are Maintained by Nephronophthisis 3-Associated Primary Cilium Formation via ROS-Induced erk and HIF-1α Activation under Serum-Deprived Normoxic Condition.
Lee JW; Cho JY; Thuy PX; Moon EY
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498831
[TBL] [Abstract] [Full Text] [Related]
13. Plasma activated medium prepared by a bipolar microsecond-pulsed atmospheric pressure plasma jet array induces mitochondria-mediated apoptosis in human cervical cancer cells.
Jo A; Joh HM; Bae JH; Kim SJ; Chung TH; Chung JW
PLoS One; 2022; 17(8):e0272805. PubMed ID: 35939492
[TBL] [Abstract] [Full Text] [Related]
14. Blocking TIGIT/CD155 signalling reverses CD8
Liu L; Wang A; Liu X; Han S; Sun Y; Zhang J; Guo L; Zhang Y
J Transl Med; 2022 Jun; 20(1):280. PubMed ID: 35729552
[TBL] [Abstract] [Full Text] [Related]
15. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/erk/c-Myc pathway in cervical cancer cells.
Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
[TBL] [Abstract] [Full Text] [Related]
16. Cobimetinib Sensitizes cervical cancer to Paclitaxel via Suppressing Paclitaxel-Induced erk Activation.
Liu Y; Zhao R; Qin X; Mao X; Li Q; Fang S
Pharmacology; 2022; 107(7-8):398-405. PubMed ID: 35526525
[TBL] [Abstract] [Full Text] [Related]
17. Ethyl β-Carboline-3-Carboxylate Increases cervical cancer Cell Apoptosis Through ROS-p38 MAPK Signaling Pathway.
Sun HN; Xie DP; Ren CX; Guo XY; Zhang HN; Xiao WQ; Han YH; Cui YD; Kwon T
In Vivo; 2022; 36(3):1178-1187. PubMed ID: 35478127
[TBL] [Abstract] [Full Text] [Related]
18. Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer.
Zhang Y; Li N; Yuan G; Yao H; Zhang D; Li N; Zhang G; Sun Y; Wang W; Zeng J; Xu N; Liu M; Wu L
BMC Med; 2022 Feb; 20(1):55. PubMed ID: 35130902
[TBL] [Abstract] [Full Text] [Related]
19. Angelol-A exerts anti-metastatic and anti-angiogenic effects on human cervical carcinoma cells by modulating the phosphorylated-erk/miR-29a-3p that targets the MMP2/VEGFA axis.
Ying TH; Lin CL; Chen PN; Wu PJ; Liu CJ; Hsieh YH
Life Sci; 2022 May; 296():120317. PubMed ID: 35026214
[TBL] [Abstract] [Full Text] [Related]
20. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer.
Huang H; Han Q; Zheng H; Liu M; Shi S; Zhang T; Yang X; Li Z; Xu Q; Guo H; Lu F; Wang J
Cell Death Dis; 2021 Dec; 13(1):13. PubMed ID: 34930918
[TBL] [Abstract] [Full Text] [Related]
[Next]
